Drug Translation & Evidence (DTE) is an international, peer-reviewed journal dedicated to advancing the discovery, development, evaluation, and evidence-based use of drugs and therapeutics. The journal aims to disseminate high-quality research spanning basic and translational pharmacology, preclinical research, clinical studies, evidence synthesis, guideline development, and the implementation of therapeutic evidence. Its mission is to bridge the gap between scientific discoveries and clinical applications, strengthen the evidence base for therapeutic decision-making, and contribute to improved patient care and health outcomes.

The scope of DTE includes, but is not limited to:

• Basic and translational pharmacology

• Drug discovery and development

• Preclinical studies with translational relevance

• Clinical trials and clinical research

• Observational studies and real-world evidence

• Pharmacokinetics and pharmacodynamics

• Drug safety and pharmacovigilance

• Comparative effectiveness research

• Systematic reviews and meta-analyses

• Evidence-based clinical practice guidelines and consensus statements

• Methodological studies in clinical research and evidence synthesis

• Health technology assessments and economic evaluations

• Implementation of therapeutic evidence in clinical practice

• Reviews and perspectives on drug development and evidence-based therapeutics